Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

60.29 USD +0.39 (+0.65%)
Official Closing Price Updated: 4:25 PM EDT, Sep 30, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,298,695
Open 60.14
Bid (Size) 60.11 (3)
Ask (Size) 60.25 (1)
Prev. Close 59.90
Today's Range 59.79 - 60.64
52wk Range 45.76 - 68.34
Shares Outstanding 1,634,538,458
Dividend Yield 2.65%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Health Canada Approves REBLOZYL® (luspatercept), New Class of Treatment for Adult Patients Living with Beta Thalassemia
Bristol Myers Squibb Canada (BMS) and Acceleron Pharma Inc. (NASDAQ:XLRN) announced today that Health Canada has approved REBLOZYL® (luspatercept) for the treatment of adult patients with red blood... 
From Business Wire News Releases
Opdivo (nivolumab) Significantly Improves Disease Free-Survival vs. Placebo as Adjuvant Therapy for Patients with High-Risk, Muscle-Invasive Urothelial Carcinoma in Phase 3 CheckMate -274 Trial
Opdivo Significantly Improves Disease Free-Survival vs. Placebo as Adjuvant Therapy for Patients with High-Risk, Muscle-Invasive Urothelial..... 
From Business Wire News Releases

Performance

YTD
-4.82%
-4.82%
1 Month
-3.07%
-3.07%
3 Month
+2.53%
+2.53%
6 Month
+8.16%
+8.16%
1 Year
+18.89%
+18.89%

More News

Read More
Notable ETF Outflow Detected - XLV, TMO, ABBV, BMY
Tags ETFs
From ETF Channel
U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb and bluebird bio Application for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121)
From Business Wire News Releases
ROCE Insights For Bristol-Myers Squibb
Tags Earnings Market News Benzinga
From Benzinga
Bristol Myers Squibb Completes Acquisition of Forbius
From Business Wire News Releases
Opdivo (nivolumab) Demonstrated Superior Disease-Free Survival in Patients with Resected Esophageal or Gastroesophageal Junction Cancer Compared to Placebo in the Adjuvant Setting
From Business Wire News Releases
6 Stocks Moving In Thursday's After Hours Session
Tags Penny Stocks Market News BMY
From Benzinga
Opdivo (nivolumab) Plus Chemotherapy Demonstrated Significant Overall and Progression-Free Survival Benefits Versus Chemotherapy in First-Line Treatment of Gastric and Esophageal Cancers
From Business Wire News Releases
73 Firms Going Ex-Dividend Next Week, Including Cardinal Health, Realty Income And Cisco Systems
Tags Stocks / Equities
From Blogs - TalkMarkets
June 2021 Options Now Available For Bristol-Myers Squibb (BMY)
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.